Saint-Gobain Life Sciences

Saint-Gobain Life Sciences is investing over EUR 70 million over three years to expand or build manufacturing facilities at seven sites in the USA, France, Ireland, India, China and South Korea, all due to be operational by the end of 2020.

Saint-Gobain Life Sciences finished construction of an 80,000 sq ft facility in Largo, Florida, to make C-Flex tubing and molded fluid management assemblies for biopharmaceutical manufacturing.